Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tuesdaynightridon Nov 24, 2014 5:14pm

172 Views

Post# 23159774

RE:RE:RE:RE:Testing on vet animal model for bigger tumors ...

Auralase light to chemical reaction created heat in the cancer cell. As you know, the TLT light to chemical reaction of TLT creates an O2 molecule. We've not really heard anything of substance from Nanospectra (or whatever it was called) since. One might suspect it was only partially effective.

Bullboard Posts

Covalon Technologies posts third profitable quarter in a row